UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
User-friendly budget setup methods can make budgeting easier. Discover techniques to streamline your budgeting process.
13,784 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Investors chasing a gold tilt in their IRAs may face tax bites that trim gains more than expected. The IRS treats phy...
What if a philanthropic powerhouse holds a large share of its stock in just a few mega-cap names? This article explor...
A little-known income ETF has doubled this year by selling covered calls on AMD, outperforming the broad market as th...
BitMine is tapping an established finance model to raise money for Ethereum buys. This article breaks down how a 9.5%...
Microsoft stands at the crossroads of cloud infrastructure and productivity software, offering a durable growth thesi...
IonQ stock ended this week in the green after an early dip. Here’s what moved the quantum-computing name and how regu...
Saia stock swooned this week after a high-profile downgrade rattled traders, even as some metrics showed resilience. ...
McDonald’s shares fell toward a 52-week low even as quarterly results underscored growing global sales. Investors wei...
NVIDIA stock steadies after a summer pullback as analysts largely stay bullish. Here’s a fresh look at the nvidia sto...
On Independence Day, traditional markets pause while Bitcoin continues to trade worldwide. The day showcases how bitc...
Oil prices have cooled, yet a veteran observer warns that upside risks could re-emerge. OPEC+ supply increases, Hormu...